
### [MONDO:0002123](http://purl.obolibrary.org/obo/MONDO_0002123)
**Label:** calcinosis

**Subclasses:** [MONDO:0017215](http://purl.obolibrary.org/obo/MONDO_0017215) (calciphylaxis), [MONDO:0018891](http://purl.obolibrary.org/obo/MONDO_0018891) (familial tumoral calcinosis), 

**Corr. equiv. classes:** [Orphanet:53715](http://www.orpha.net/ORDO/Orphanet_53715), [Orphanet:280062](http://www.orpha.net/ORDO/Orphanet_280062), 

**Class expressions from DL-Learner:**

- [HP:0000867](http://purl.obolibrary.org/obo/HP_0000867) (Secondary hyperparathyroidism) and [HP:0200042](http://purl.obolibrary.org/obo/HP_0200042) (Skin ulcer) 75.00%
- [HP:0000867](http://purl.obolibrary.org/obo/HP_0000867) (Secondary hyperparathyroidism) and [HP:0100806](http://purl.obolibrary.org/obo/HP_0100806) (Sepsis) 75.00%
- [HP:0000867](http://purl.obolibrary.org/obo/HP_0000867) (Secondary hyperparathyroidism) and [HP:0100758](http://purl.obolibrary.org/obo/HP_0100758) (Gangrene) 75.00%
- [HP:0000867](http://purl.obolibrary.org/obo/HP_0000867) (Secondary hyperparathyroidism) and [HP:0100658](http://purl.obolibrary.org/obo/HP_0100658) (Cellulitis) 75.00%
- [HP:0000867](http://purl.obolibrary.org/obo/HP_0000867) (Secondary hyperparathyroidism) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 75.00%
- [HP:0000867](http://purl.obolibrary.org/obo/HP_0000867) (Secondary hyperparathyroidism) and [HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology) 75.00%
- [HP:0000867](http://purl.obolibrary.org/obo/HP_0000867) (Secondary hyperparathyroidism) and [HP:0012622](http://purl.obolibrary.org/obo/HP_0012622) (Chronic kidney disease) 75.00%
- [HP:0000867](http://purl.obolibrary.org/obo/HP_0000867) (Secondary hyperparathyroidism) and [HP:0012211](http://purl.obolibrary.org/obo/HP_0012211) (Abnormal renal physiology) 75.00%
- [HP:0000867](http://purl.obolibrary.org/obo/HP_0000867) (Secondary hyperparathyroidism) and [HP:0011986](http://purl.obolibrary.org/obo/HP_0011986) (Ectopic ossification) 75.00%
- [HP:0000867](http://purl.obolibrary.org/obo/HP_0000867) (Secondary hyperparathyroidism) and [HP:0011915](http://purl.obolibrary.org/obo/HP_0011915) (Cardiovascular calcification) 75.00%
- [HP:0000867](http://purl.obolibrary.org/obo/HP_0000867) (Secondary hyperparathyroidism) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 75.00%
- [HP:0000867](http://purl.obolibrary.org/obo/HP_0000867) (Secondary hyperparathyroidism) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 75.00%
- [HP:0000867](http://purl.obolibrary.org/obo/HP_0000867) (Secondary hyperparathyroidism) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) 75.00%
- [HP:0000867](http://purl.obolibrary.org/obo/HP_0000867) (Secondary hyperparathyroidism) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) 75.00%
- [HP:0000867](http://purl.obolibrary.org/obo/HP_0000867) (Secondary hyperparathyroidism) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 75.00%


